OBJECTIVE: The aim of this study was to investigate the plasma concentrations of vitamin D and its association with plasma lipid profiles. METHODS: Plasma vitamin D3 and lipid concentrations were measured in 119 female cynomolgus monkeys (premenopausal, n = 49; ovariectomized, n = 70) consuming approximately 1,000 IU per day of vitamin D3. In a subset of the ovariectomized monkeys (n = 23), vitamin D3 was remeasured after 6 months. The concentrations of vitamin D3 were analyzed as a continuous variable and were divided at the median into high (≥48 ng/mL) versus low (<48 ng/mL) groupings. RESULTS: Among the 119 monkeys, the range of vitamin D3 concentrations was 24.0 to 95.2 ng/mL (mean ± SD, 48.5 ± 12.7 ng/mL). Plasma vitamin D3 concentration was positively associated with high-density lipoprotein cholesterol (HDL-C; P = 0.003). Monkeys in the high vitamin D3 group had a significantly greater plasma HDL-C concentration (57.9 mg/dL) than did those in the low vitamin D3 group (47.1 mg/dL; P = 0.001). Although the difference was not significant (P = 0.120), the monkeys in the high vitamin D3 group had a decreased total plasma cholesterol-to-HDL-C ratio compared with those in the low vitamin D3 group (5.4 and 6.2, respectively), potentially putting them at lower risk of atherosclerosis development. CONCLUSIONS: Given that the monkeys all consumed a diet replete in vitamin D3, it seems that individual differences in vitamin D absorption or metabolism may have determined whether the monkeys had high or low concentrations of vitamin D3. Lower vitamin D3 was associated with a more atherogenic lipid profile, a major risk factor for progressing to coronary artery atherosclerosis in monkeys and human beings.
OBJECTIVE: The aim of this study was to investigate the plasma concentrations of vitamin D and its association with plasma lipid profiles. METHODS: Plasma vitamin D3 and lipid concentrations were measured in 119 female cynomolgus monkeys (premenopausal, n = 49; ovariectomized, n = 70) consuming approximately 1,000 IU per day of vitamin D3. In a subset of the ovariectomized monkeys (n = 23), vitamin D3 was remeasured after 6 months. The concentrations of vitamin D3 were analyzed as a continuous variable and were divided at the median into high (≥48 ng/mL) versus low (<48 ng/mL) groupings. RESULTS: Among the 119 monkeys, the range of vitamin D3 concentrations was 24.0 to 95.2 ng/mL (mean ± SD, 48.5 ± 12.7 ng/mL). Plasma vitamin D3 concentration was positively associated with high-density lipoprotein cholesterol (HDL-C; P = 0.003). Monkeys in the high vitamin D3 group had a significantly greater plasma HDL-C concentration (57.9 mg/dL) than did those in the low vitamin D3 group (47.1 mg/dL; P = 0.001). Although the difference was not significant (P = 0.120), the monkeys in the high vitamin D3 group had a decreased total plasma cholesterol-to-HDL-C ratio compared with those in the low vitamin D3 group (5.4 and 6.2, respectively), potentially putting them at lower risk of atherosclerosis development. CONCLUSIONS: Given that the monkeys all consumed a diet replete in vitamin D3, it seems that individual differences in vitamin D absorption or metabolism may have determined whether the monkeys had high or low concentrations of vitamin D3. Lower vitamin D3 was associated with a more atherogenic lipid profile, a major risk factor for progressing to coronary artery atherosclerosis in monkeys and human beings.
Authors: Rasa Kazlauskaite; Lynda H Powell; Chaitanya Mandapakala; John F Cursio; Elizabeth F Avery; James Calvin Journal: J Clin Lipidol Date: 2010-02-06 Impact factor: 4.766
Authors: Anastassios G Pittas; Bess Dawson-Hughes; Tricia Li; Rob M Van Dam; Walter C Willett; Joann E Manson; Frank B Hu Journal: Diabetes Care Date: 2006-03 Impact factor: 19.112
Authors: Stefan Pilz; Winfried März; Britta Wellnitz; Ursula Seelhorst; Astrid Fahrleitner-Pammer; Hans P Dimai; Bernhard O Boehm; Harald Dobnig Journal: J Clin Endocrinol Metab Date: 2008-08-05 Impact factor: 5.958
Authors: Peter F Schnatz; Matthew Nudy; David M O'Sullivan; Xuezhi Jiang; J Mark Cline; Jay R Kaplan; Thomas B Clarkson; Susan E Appt Journal: Menopause Date: 2012-09 Impact factor: 2.953
Authors: Matthew J Jorgensen; Lawrence L Rudel; Matthew Nudy; Jay R Kaplan; Thomas B Clarkson; Nicholas M Pajewski; Peter F Schnatz Journal: J Womens Health (Larchmt) Date: 2012-08-09 Impact factor: 2.681
Authors: Peter F Schnatz; Sharon Vila-Wright; Xuezhi Jiang; Thomas C Register; Jay R Kaplan; Thomas B Clarkson; Susan E Appt Journal: Menopause Date: 2012-10 Impact factor: 2.953
Authors: Peter F Schnatz; Matthew Nudy; David M O'Sullivan; Xuezhi Jiang; J Mark Cline; Jay R Kaplan; Thomas B Clarkson; Susan E Appt Journal: Maturitas Date: 2012-04-26 Impact factor: 4.342
Authors: Peter F Schnatz; Xuezhi Jiang; Sharon Vila-Wright; Aaron K Aragaki; Matthew Nudy; David M O'Sullivan; Rebecca Jackson; Erin LeBlanc; Jennifer G Robinson; James M Shikany; Catherine R Womack; Lisa W Martin; Marian L Neuhouser; Mara Z Vitolins; Yiqing Song; Stephen Kritchevsky; JoAnn E Manson Journal: Menopause Date: 2014-08 Impact factor: 2.953
Authors: Seung Joo Chon; Bo Hyon Yun; Yeon Soo Jung; Si Hyun Cho; Young Sik Choi; Suk Young Kim; Byung Seok Lee; Seok Kyo Seo Journal: PLoS One Date: 2014-02-21 Impact factor: 3.240